Micro-Tech 南微医学
4 significant filings since 31 May 2026: 2 on regulatory inquiry and 2 on dividend. The latest, on 27 Aug 2026: 2026-016 南微医学科技股份有限公司关于2026年半年度利润分配方案的公告.
自 31 May 2026 起有 4 份重大公告：regulatory inquiry 2 份、dividend 2 份。最新一份（27 Aug 2026）：2026-016 南微医学科技股份有限公司关于2026年半年度利润分配方案的公告。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 3.20 | 3.81 |
| 7 days ago | 3.20 | 3.81 |
| 30 days ago | 3.53 | 4.12 |
| 60 days ago | 3.55 | 4.14 |
| 90 days ago | 3.55 | 4.14 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 4.96 in Sep 2024 to 3.20 in Sep 2026 (-35.5%). 一致预期从 Sep 2024 的 4.96 变为 Sep 2026 的 3.20 (-35.5%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 2 = 0 | ▲ 0 ▼ 2 = 0 |
| Last 90 days | ▲ 0 ▼ 4 = 0 | ▲ 0 ▼ 4 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2019 | 31 Mar 2020 | 2.25 | 3 | 2.67 | +18.3% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 2. 惊喜幅度需公告前120天内至少3家券商预测；FY2025仅1家；FY2024仅2家。